Developments in drugs (AQA GCSE History): Revision Notes
Developments in drugs
The changing focus of medicine
At the start of the 20th century, medical treatment remained largely focused on managing diseases rather than curing them, as doctors still had limited ability to actually cure most conditions. This fundamental approach began to shift dramatically with the discovery of penicillin and the rapid growth of the pharmaceutical industry, which researches, produces and sells medicines on a massive scale.
The pharmaceutical industry as we know it today - with massive research facilities, global distribution networks, and billion-dollar drug development programmes - simply didn't exist before the mid-20th century. The success of penicillin essentially created the modern pharmaceutical industry.
The discovery and development of penicillin
Fleming's accidental breakthrough (1928)
The story of penicillin began with a stroke of luck in Alexander Fleming's laboratory. While tidying his lab, Fleming noticed something remarkable in a Petri dish that had been left out - mould had begun growing on it, and crucially, the mould had killed some of the bacteria surrounding it. Fleming quickly recognised the significance of this observation and worked out which bacteria the penicillin mould could destroy. He documented this groundbreaking discovery in a medical journal, though at this stage it remained largely theoretical.
Fleming's discovery demonstrates how chance plays a crucial role in scientific breakthroughs. Many of history's most important medical discoveries have resulted from unexpected observations by alert scientists who recognised the significance of what they were seeing.
From discovery to practical medicine (1938-1945)
The real breakthrough came a decade later when scientists Howard Florey and Ernst Chain took Fleming's work further in 1938. They developed a method for purifying and producing penicillin in usable quantities, transforming it from a laboratory curiosity into a potential life-saving treatment.
The urgency of World War Two accelerated development dramatically. By 1940, Florey and Chain were testing penicillin on mice, but the war meant British companies lacked sufficient funding to mass-produce the drug. This led them to seek assistance from the United States in 1941, where they established a penicillin factory at Oxford University. The trials showed positive results, and Florey travelled to America to secure US government support.
The Role of War in Medical Innovation
World War Two didn't just provide urgency - it fundamentally changed how medical research was funded and conducted. The war created unprecedented collaboration between scientists, governments, and industry, establishing a model for large-scale medical research that continues today.
The first major clinical trial took place in 1943 when Florey tested the drug on wounded soldiers in North Africa, using small doses to treat war wounds. The results were extraordinary - many lives were saved, proving penicillin's effectiveness in real battlefield conditions.
By 1945, Margaret Hutchinson Rousseau had developed a mass-production method that enabled the manufacture of 650 billion doses that year alone, making penicillin widely available across Britain and beyond.
Factors driving penicillin's development
The rapid development of penicillin resulted from several interconnected factors working together:
War played a crucial role as the US government recognised penicillin's potential for treating injured soldiers, leading to substantial government investment and support for research and production.
Chance was fundamental - Fleming's initial discovery only happened because he accidentally left out a Petri dish, demonstrating how scientific breakthroughs sometimes emerge from unexpected circumstances.
Government funding proved essential when the US government provided financial backing for Florey and Chain's research, something British companies couldn't afford during wartime.
Science and technology advanced significantly through Hutchinson Rousseau's mass-production methods, which made it possible to manufacture penicillin on an industrial scale.
Individual contributions were vital - without the dedicated work of Fleming, Florey, Chain, and others, penicillin might not have been developed for many years.
The Multifactor Nature of Medical Breakthroughs
These factors demonstrate that major medical developments often require multiple elements to align, with more than one factor typically being crucial for success. This pattern continues in modern drug development, where breakthrough treatments emerge from complex combinations of scientific discovery, funding, technology, and urgent medical need.
The growth of the drug development industry
Before penicillin, drugs had been researched, tested and manufactured, but never on such an enormous scale. The success of penicillin during World War Two led to massive growth in the pharmaceutical industry. Today, this industry conducts extensive research, develops new treatments, tests them thoroughly, and produces many different types of drugs for various conditions.
Modern drug companies continue searching for cures to serious illnesses like cancer, AIDS, and the common cold. While the cost of research and development remains extremely high, pharmaceutical companies often generate substantial profits from successful drugs they develop and market.
The modern pharmaceutical industry operates on a massive scale that would have been unimaginable in Fleming's time. Today's drug development can cost billions of dollars and take 10-15 years from initial discovery to market approval, involving thousands of researchers and complex international collaborations.
Drug safety and regulation
The development of new medicines hasn't always been successful or safe. Until the 1960s, most new drugs were viewed as positive discoveries, but this changed dramatically following the thalidomide disaster. Thalidomide was prescribed to help pregnant women with morning sickness, but it caused thousands of babies to be born with severely malformed limbs.
The Thalidomide Tragedy: A Turning Point in Drug Safety
The thalidomide disaster was a watershed moment that transformed how we think about drug safety. It demonstrated that even seemingly harmless medications can have devastating consequences, leading to the establishment of rigorous testing protocols that are still used today. This tragedy serves as a permanent reminder that thorough testing and regulation are essential for protecting public health.
This tragedy led to much stricter controls on drug testing and approval processes in many countries, including Britain. Interestingly, thalidomide is now used to treat AIDS and leprosy, though it remains highly controversial due to its tragic history.
Timeline of key events
- 1928: Alexander Fleming discovers penicillin mould kills bacteria
- 1938: Howard Florey and Ernst Chain develop purification method
- 1940: Animal testing begins; funding becomes an issue due to WWII
- 1941: Penicillin factory established at Oxford; US government support secured
- 1943: First major clinical trials on wounded soldiers in North Africa
- 1945: Mass production begins - 650 billion doses produced
- 1960s: Thalidomide disaster leads to stricter drug regulations
Key Points to Remember:
- Fleming's discovery of penicillin in 1928 was accidental - showing how chance plays a role in medical breakthroughs
- Multiple factors drove penicillin's development: war, government funding, scientific advances, and individual dedication all contributed
- World War Two accelerated penicillin development through urgent need and US government investment
- The pharmaceutical industry grew massively after penicillin's success, focusing on research and mass production
- The thalidomide disaster in the 1960s led to much stricter drug testing and safety regulations worldwide